# Influence of Esomeprazole on Antiplatelet Action of Clopidogrel Associated With Aspirin

> **NCT01062516** · PHASE4 · COMPLETED · sponsor: **Ruttonjee Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Acute Coronary Syndrome
- Acute Myocardial Infarction

## Interventions

- **DRUG:** esomeprazole 20 mg daily
- **DRUG:** famotidine 40 mg daily

## Key facts

- **NCT ID:** NCT01062516
- **Lead sponsor:** Ruttonjee Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2010-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01062516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01062516, "Influence of Esomeprazole on Antiplatelet Action of Clopidogrel Associated With Aspirin". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01062516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*